Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jingying Xu"'
Autor:
Louis Lacombe, Gideon Bollag, James L. Sung, Ziyue Karen Jiang, Yves Fradet, Clara E. Magyar, Jemima Escamilla, Shiruyeh Schokrpur, Michael E. Jung, Gang Deng, Lily Wu, Connie Y Liu, Jingying Xu, Saul J. Priceman, Brian L. West, Diana Moughon, Jiaoti Huang, Frédéric Pouliot
Publikováno v:
Cancer research, vol 75, iss 6
Escamilla, J; Schokrpur, S; Liu, C; Priceman, SJ; Moughon, D; Jiang, Z; et al.(2015). CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer Research, 75(6), 950-962. doi: 10.1158/0008-5472.CAN-14-0992. UCLA: Retrieved from: http://www.escholarship.org/uc/item/16x1m52m
Escamilla, J; Schokrpur, S; Liu, C; Priceman, SJ; Moughon, D; Jiang, Z; et al.(2015). CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy. Cancer Research, 75(6), 950-962. doi: 10.1158/0008-5472.CAN-14-0992. UCLA: Retrieved from: http://www.escholarship.org/uc/item/16x1m52m
Growing evidence suggests that tumor-associated macrophages (TAM) promote cancer progression and therapeutic resistance by enhancing angiogenesis, matrix-remodeling, and immunosuppression. In this study, prostate cancer under androgen blockade therap
Autor:
Saul J. Priceman, Jemima Escamilla, John R. David, Gideon Bollag, Lily Wu, William H. McBride, Brian L. West, Stephen Mok, Jingying Xu
Publikováno v:
Journal of Urology. 191:270-271
Radiotherapy is used to treat many types of cancer, but many treated patients relapse with local tumor recurrence. Tumor-infiltrating myeloid cells (TIM), including CD11b (ITGAM)+F4/80 (EMR1)+ tumor-associated macrophages (TAM), and CD11b+Gr-1 (LY6G)
Publikováno v:
Molecular Cancer Therapeutics. 10:C227-C227
Radiotherapy is one of the major frontline treatments for prostate cancer (PCa). However, a large proportion of patients suffer from tumor recurrence after radiotherapy. Tumor-infiltrating myeloid cells (TIMs), including CD11b+F4/80+ tumor-associated
Publikováno v:
Molecular Cancer Therapeutics. 10:C226-C226
There is growing evidence for the role of inflammation in prostate cancer (PCa) progression, although the precise role of inflammation in the context of androgen ablation therapy remains unclear. Various reports demonstrate that androgen deprivation
Publikováno v:
Nano Biomedicine & Engineering; 2012, Vol. 4 Issue 2, p76-82, 7p, 2 Black and White Photographs, 2 Diagrams, 5 Graphs